NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球peptide療法市場:按類型、合成技術、製造類型、用途、地區和冠狀病毒感染 (COVID-19) 的潛在影響的見解和預測 (2021-2025)

Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2021-2025)

出版商 Koncept Analytics 商品編碼 1022970
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
全球peptide療法市場:按類型、合成技術、製造類型、用途、地區和冠狀病毒感染 (COVID-19) 的潛在影響的見解和預測 (2021-2025) Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2021-2025)
出版日期: 2021年08月11日內容資訊: 英文 117 Pages
簡介

預計2021年至2025年全球peptide療法市場將以6.95%的複合年增長率增長,到2025年將達到422.2億美元。這是由於癌症激增、醫療成本上升、代謝紊亂髮病率增加、老年人數量增加以及基於peptide的療法的批准數量增加。然而,仿製藥和生物仿製藥的存在、高昂的開發成本、嚴格的法規以及多peptide生產的複雜性預計將阻礙市場增長。

本報告調查了全球多peptide治療市場,包括市場概況、市場規模趨勢和按類型、合成技術、製造類型、應用和地區、市場增長因素、主要趨勢、挑戰和競爭條件的預測。主要公司簡介等進行了總結。

目錄

第 1 章市場概覽

  • 簡介
  • 多peptide製造工藝
  • peptide分類
  • 治療性peptide和蛋白質的功能分類
  • peptide類藥物示例
  • 治療peptide的優缺點
  • 早期peptide的來源或化學性質

第 2 章嚴重急性呼吸系統綜合症 (COVID-19) 的影響

第三章世界市場分析

  • peptide治療市場:基於數量
  • peptide治療市場預測:基於價值
  • peptide治療藥物市場:按類型
    • 創新peptide療法
    • 晚期peptide治療劑
  • peptide治療藥物市場:通過合成技術
    • 固相
    • 液相
    • 混合
  • peptide治療藥物市場:按製造類型
    • 外包
    • 內部
  • peptide治療藥物市場:按應用
    • 代謝紊亂
    • 腫瘤
    • 胃腸道疾病
    • 心血管疾病
    • 神經系統疾病
  • peptide治療藥物市場:按地區

第 4 章全球peptide治療市場分析:按地區

  • 北美
  • 歐洲/中東/非洲
  • 亞太地區
  • 拉丁美洲

第 5 章市場動態

  • 增長因素
    • 癌症患病率迅速增加
    • 醫療費用增加
    • 代謝紊亂的發生率增加
    • 老年人口增加
    • 基於peptide的療法的批准迅速增加
  • 主要趨勢和發展
    • 仿製藥對多peptide的推廣
    • 快速採用外包peptide API
    • 加大新藥研發投入
  • 挑戰
    • 仿製藥或生物仿製藥peptide療法的可用性
    • 藥物開發成本高,監管要求嚴格
    • 多peptide生產的複雜性

第6章競爭形勢

  • 世界市場
    • 各大公司利潤對比
    • 各大公司市值對比
    • 各大公司研發對比

第七章公司簡介

  • Novartis International AG
  • GlaxoSmithKline PLC
  • Bristol Myers Squibb Co.
  • Amgen Inc.
  • Eli Lilly and Company
  • PolyPeptide Group AG
目錄

The global peptide therapeutics market is expected to record a value of US$42.22 billion in 2025, witnessing growth at a CAGR of 6.95%, for the duration spanning 2021-2025. The factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs. However, the market growth would be challenged by availability of generic or biosimilar peptide therapeutic drugs, high cost of developing drugs and stringent regulatory requirements and production complexity of peptides. The market is anticipated to experience certain trends like expanding volume of peptides driven by generics, rapid adoption of outsourced peptide API and rising investments in research and development of novel drugs.

The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application. Based on type, the market can be bifurcated into innovative and generic. According to synthesis technology, the market can be categorized into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) and Hybrid Technology. Whereas, on the basis of manufacturing type, the market can be divided outsourced and in-house. In terms of application, the global peptide therapeutics market can be split into chemotherapy, gastroenterology, analgesia, diabetes, pediatric & neonatology and other applications.

The fastest growing regional market is North America due to increasing research and development activities for the development of innovative peptide therapeutics and improvements in healthcare infrastructure coupled with growing prescription of peptide therapeutics on account of high presence of a large number of patients with chronic diseases such as diabetes and cancer.

Scope of the report:

  • The report provides a comprehensive analysis of the global peptide therapeutics market segmented on the basis of type, synthesis technology, manufacturing type and application region.
  • The major regional and country markets (North America, Europe, Middle East & Africa, Asia Pacific and Latin America) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co., Amgen Inc., Eli Lilly and Company and PolyPeptide Group AG) are also presented in detail.

Key Target Audience:

  • Peptide Manufacturers, Suppliers & Distributors
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Manufacturing Process of Peptides
  • 1.3 Classification of Peptides
  • 1.4 Functional Classification of Therapeutic Peptides & Proteins
  • 1.5 Examples of Peptide-based Drugs
  • 1.6 Advantages and Disadvantages of Therapeutic Peptides
  • 1.7 Source or Chemical Nature of Early Peptides

2. Impact of COVID-19

  • 2.1 Adoption of Peptides in COVID-19 Related Research
  • 2.2 Disruptions in Clinical Trials

3. Global Market Analysis

  • 3.1 Global Peptide Therapeutics Market by Value
  • 3.2 Global Peptide Therapeutics Market Forecast by Value
  • 3.3 Global Peptide Therapeutics Market by Type
    • 3.3.1 Global Innovative Peptide Therapeutics Market by Value
    • 3.3.2 Global Innovative Peptide Therapeutics Market Forecast by Value
    • 3.3.3 Global Generic Peptide Therapeutics Market by Value
    • 3.3.4 Global Generic Peptide Therapeutics Market Forecast by Value
  • 3.4 Global Peptide Therapeutics Market by Synthesis Technology
    • 3.4.1 Global Solid Phase Peptide Synthesis Therapeutics Market by Value
    • 3.4.2 Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value
    • 3.4.3 Global Liquid Phase Peptide Synthesis Therapeutics Market by Value
    • 3.4.4 Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value
    • 3.4.5 Global Hybrid Technology Synthesis Therapeutics Market by Value
    • 3.4.6 Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value
  • 3.5 Global Peptide Therapeutics Market by Manufacturing Type
    • 3.5.1 Global Outsourced Peptide Therapeutics Market Forecast by Value
    • 3.5.2 Global In-house Peptide Therapeutics Market Forecast by Value
  • 3.6 Global Peptide Therapeutics Market by Application
    • 3.6.1 Global Metabolic Disorders Peptide Therapeutics Market by Value
    • 3.6.2 Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value
    • 3.6.3 Global Oncology Peptide Therapeutics Market by Value
    • 3.6.4 Global Oncology Peptide Therapeutics Market Forecast by Value
    • 3.6.5 Global Gastrointestinal Disorders Peptide Therapeutics Market by Value
    • 3.6.6 Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value
    • 3.6.7 Global Cardiovascular Disorders Peptide Therapeutics Market by Value
    • 3.6.8 Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value
    • 3.6.9 Global Neurological Disorders Peptide Therapeutics Market by Value
    • 3.6.10 Global Neurological Disorders Peptide Therapeutics Market Forecast by Value
  • 3.7 Global Peptide Therapeutics Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Peptide Therapeutics Market by Value
    • 4.1.2 North America Peptide Therapeutics Market Forecast by Value
    • 4.1.3 The U.S. Peptide Therapeutics Market Forecast by Value
    • 4.1.4 The U.S. Peptide Therapeutics Market Forecast by Type
  • 4.2 Europe, Middle East & Africa
    • 4.2.1 Europe, Middle East & Africa Peptide Therapeutics Market by Value
    • 4.2.2 Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Peptide Therapeutics Market by Value
    • 4.3.2 Asia Pacific Peptide Therapeutics Market Forecast by Value
  • 4.4 Latin America
    • 4.4.1 Latin America Peptide Therapeutics Market by Value
    • 4.4.2 Latin America Peptide Therapeutics Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Surging Prevalence of Cancer
    • 5.1.2 Rising Healthcare Expenditure
    • 5.1.3 Growing Incidence of Metabolic Disorders
    • 5.1.4 Increasing Geriatric Population
    • 5.1.5 Accelerating Number of Approved Peptide-based Therapeutic Drugs
  • 5.2 Key Trends and Developments
    • 5.2.1 Expanding Volume of Peptides driven by Generics
    • 5.2.2 Rapid Adoption of Outsourced Peptide API
    • 5.2.3 Rising Investments in Research and Development of Novel Drugs
  • 5.3 Challenges
    • 5.3.1 Availability of Generic or Biosimilar Peptide Therapeutic Drugs
    • 5.3.2 High Cost of Developing Drugs and Stringent Regulatory Requirements
    • 5.3.3 Production Complexity of Peptides

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players

7. Company Profiles

  • 7.1 Novartis International AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 GlaxoSmithKline PLC
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Bristol Myers Squibb Co.
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Amgen Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Eli Lilly and Company
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 PolyPeptide Group AG
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies

List of Figures

  • Manufacturing Process of Peptides
  • Classification of Peptides
  • Functional Classification of Therapeutic Peptides & Proteins
  • Advantages and Disadvantages of Therapeutic Peptides
  • Global Most Affected Clinical Trials by Therapy Area (2020)
  • Global Peptide Therapeutics Market by Value (2016-2020)
  • Global Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Peptide Therapeutics Market by Type (2020)
  • Global Innovative Peptide Therapeutics Market by Value (2016-2020)
  • Global Innovative Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Generic Peptide Therapeutics Market by Value (2016-2020)
  • Global Generic Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Peptide Therapeutics Market by Synthesis Technology (2020)
  • Global Solid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
  • Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
  • Global Liquid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
  • Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
  • Global Hybrid Technology Synthesis Therapeutics Market by Value (2016-2020)
  • Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value (2021-2025)
  • Global Peptide Therapeutics Market by Manufacturing Type (2020)
  • Global Outsourced Peptide Therapeutics Market Forecast by Value (2020-2025)
  • Global In-house Peptide Therapeutics Market Forecast by Value (2020-2025)
  • Global Peptide Therapeutics Market by Application (2020)
  • Global Metabolic Disorders Peptide Therapeutics Market by Value (2016-2020)
  • Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Oncology Peptide Therapeutics Market by Value (2016-2020)
  • Global Oncology Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Gastrointestinal Disorders Peptide Therapeutics Market by Value (2016-2020)
  • Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Cardiovascular Disorders Peptide Therapeutics Market by Value (2016-2020)
  • Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Neurological Disorders Peptide Therapeutics Market by Value (2016-2020)
  • Global Neurological Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Peptide Therapeutics Market by Region (2020)
  • North America Peptide Therapeutics Market by Value (2016-2020)
  • North America Peptide Therapeutics Market Forecast by Value (2021-2025)
  • The U.S. Peptide Therapeutics Market Forecast by Value (2020-2025)
  • The U.S. Peptide Therapeutics Market by Type (2020-2025)
  • Europe, Middle East & Africa Peptide Therapeutics Market by Value (2016-2020)
  • Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Asia Pacific Peptide Therapeutics Market by Value (2016-2020)
  • Asia Pacific Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Latin America Peptide Therapeutics Market by Value (2016-2020)
  • Latin America Peptide Therapeutics Market Forecast by Value (2021-2025)
  • Global Cancer Prevalence (2018-2023)
  • Global Healthcare Expenditure Per Capita (2016-2020)
  • Global Diabetes Prevalence (2010-2045)
  • Global Population Ages 65 Years and Above (2016-2020)
  • Number of Approved/Launched Peptide Therapeutic Drugs Worldwide (2020-2025)
  • Global GLP-1 Market Development (2018-2027)
  • Global In-House vs. Outsourced Peptide API Market Development (2020-2025)
  • Global Spending on Pharmaceutical Research and Development (2018-2026)
  • Global Biosimilar Therapeutic Peptides Market (2020-2025)
  • Novartis International AG Net Sales and Net Income (2016-2020)
  • Novartis International AG Net Sales by Segment (2020)
  • Novartis International AG Net Sales by Region (2020)
  • GlaxoSmithKline PLC Turnover and Profit (2016-2020)
  • GlaxoSmithKline PLC Turnover by Segment (2020)
  • GlaxoSmithKline PLC Turnover by Region (2020)
  • Bristol Myers Squibb Co. Total Revenue and Net Earnings (2016-2020)
  • Bristol Myers Squibb Co. Total Revenue by Region (2020)
  • Amgen Inc. Revenue and Net Income (2016-2020)
  • Amgen Inc. Revenue by Region (2020)
  • Eli Lilly and Company Revenue and Net Income (2016-2020)
  • Eli Lilly and Company Revenue by Region (2020)
  • PolyPeptide Group AG Revenue and Net Income (2018-2020)
  • PolyPeptide Group AG Revenue by Segment (2020)
  • PolyPeptide Group AG Revenue by Region (2020)

List of Tables

  • Difference between Peptides, Small Molecules & Biologics
  • Examples of Peptide-based Drugs Available in the Market
  • Source or Chemical Nature of Early Peptides
  • Synthetic Peptides in Development of COVID-19 (2020)
  • Revenue Comparison of Key Players (2020)
  • Market Capitalization Comparison of Key Players (2021)
  • R&D Comparison of Key Players (2020)